OPKO HEALTH, INC.
For the period ended Dec 31, 2025. Filed Feb 26, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 26, 2026
OPK$1.71-1.2%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Operations
| For the years ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Revenues: | |||
| Revenue from services | $370,275 | $480,667 | $515,275 |
| Revenue from products | 156,924 | 155,111 | 167,557 |
| Revenue from transfer of intellectual property and other | 79,680 | 77,364 | 180,663 |
| Total revenues | 606,879 | 713,142 | 863,495 |
| Costs and expenses: | |||
| Cost of service revenue | 307,350 | 402,109 | 445,830 |
| Cost of product revenue | 93,589 | 92,523 | 99,538 |
| Selling, general and administrative | 223,002 | 304,220 | 300,559 |
| Research and development | 124,033 | 105,214 | 89,593 |
| Contingent consideration | — | — | (1,036) |
| Amortization of intangible assets | 77,890 | 82,634 | 86,032 |
| Gain on sale of assets | (101,576) | (121,493) | — |
| Total costs and expenses | 724,288 | 865,207 | 1,020,516 |
| Operating loss | (117,409) | (152,065) | (157,021) |
| Other income and (expense), net: | |||
| Interest income | 14,811 | 8,426 | 3,983 |
| Interest expense | (108,462) | (47,465) | (13,506) |
| Fair value changes of derivative instruments, net | (429) | (26,161) | (781) |
| Other income (expense), net | (29,875) | 206,903 | (16,994) |
| Other income (expense), net | (123,955) | 141,703 | (27,298) |
| Loss before income taxes and investment losses | (241,364) | (10,362) | (184,319) |
| Income tax benefit (provision) | 15,713 | (42,844) | (4,437) |
| Net loss before investment losses | (225,651) | (53,206) | (188,756) |
| Loss from investments in investees | (29) | (18) | (107) |
| Net loss | $(225,680) | $(53,224) | $(188,863) |
| Loss per share basic and diluted: | |||
| Loss per share | $(0.30) | $(0.08) | $(0.25) |
| Weighted average number of common shares outstanding, basic and diluted | 751,132,891 | 694,019,535 | 751,765,915 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.